Monitoring Blood Sugar to Support Safer Insulin Use in Older Adults
Tests a group education program using glucose monitors in older adults with type 2 diabetes.
Key facts
- Who runs it
- Kaiser Permanente
- Where
- Fremont, Sacramento, San Jose, San Leandro, Santa Clara, and Union City, United StatesSee the 6 sites
- Trial code
- Registry title
- Safer Aging With Diabetes Monitoring
- Status
- Recruiting
- People taking part
- 360 people, planned
- Started
- 1 May 2024
- Expected to end
- 31 Jan 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- SAGE Group Sessions
- Usual Care
- Record updated
- 4 August 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 75 and older with type 2 diabetes who use insulin and have a higher risk of low blood sugar. It tests an education program that uses continuous glucose monitoring.
- Age
- 75 years and older
- Sex
- All sexes
- Disease stage
- Type 2 diabetes, with a higher risk of low blood sugar (hypoglycemia) in the past year, by self-report or use of health care
- Earlier treatment
- Must currently be treated with insulin. Must not have used a continuous glucose monitor (CGM) now or recently.
Main reasons for not taking part
- On renal dialysis
- Dementia
- Pacemaker or automatic implantable cardioverter defibrillator
- Using an insulin pump
- Severe mental illness, severe visual impairment, or in hospice
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Age 75 years and older
- Diagnosis of Type 2 Diabetes
- Current treatment with insulin
- Increased hypoglycemia risk (prior year hypoglycemia by self-report or utilization)
- Able to communicate in English
- Able to access email and the Internet
Who cannot take part
- Dementia
- Severe Mental Illness
- Severe Visual Impairment
- On renal dialysis
- Pacemaker or Automatic Implantable Cardioverter Defibrillator
- Using insulin pump
- In Hospice
- Current or recent CGM use
Where in United States
- Kaiser Permanente-FremontFremont, United StatesContact: Carolina GonzalezNo longer taking part
- Kaiser Permanente - SacramentoSacramento, United StatesContact: Emma FernandezTaking people
- Kaiser Permanente San JoseSan Jose, United StatesContact: Carolina GonzalezNo longer taking part
- Kaiser Permanente San LeandroSan Leandro, United StatesContact: Carolina GonzalezNo longer taking part
- Kaiser Permanente Santa ClaraSanta Clara, United StatesContact: Carolina GonzalezNo longer taking part
- Kaiser Permanente - Union CityUnion City, United StatesContact: Carolina GonzalezNo longer taking part
About the trial
What the trial wants to find out
Older adults with type 2 diabetes are at higher risk for severe hypoglycemia and its related complications (including hospitalization and death) when taking insulin. This study proposes to evaluate, in a randomized clinical trial, a strategy of safe insulin prescribing based on an educational program that leverages continuous glucose monitoring to support older adults at high risk for hypoglycemia. If the aims of this project are achieved, this novel care strategy could be widely applied to reduce severe hypoglycemia episodes in older, high-risk adults with type 2 diabetes.
The 2 groups in the trial
- Group Education SessionsTreatment being tested
Participants will participate in 3 educational sessions designed to teach about applying and using continuous glucose monitors \[CGMs\] (Session 1) and how to prevent hypoglycemia episodes based on CGM readings and hypoglycemia journal entries (Sessions 2 \& 3).
Treatment: SAGE Group Sessions
- Usual CareExisting treatment, for comparison
Participants allocated to the control arm will continue with usual care.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Pragmatic Clinical Trial of Continuous Glucose Monitoring-based Interventions for Safe Insulin Use in High-Risk Older Adults With Type 2 Diabetes
- Plain-language title
- Monitoring Blood Sugar to Support Safer Insulin Use in Older AdultsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 4 August 2026